
Patent Docs is a new weblog focusing on recent developments in biotech and pharma patent law. This weblog will offer updates regarding changes in Patent Office rules and procedures affecting biotech and pharma patent prosecution, and provide summaries of recent court and board decisions impacting biotech and pharma patent litigation and prosecution. In addition, Patent Docs will report on biotech and pharma news and highlight newly issued biotech and pharma patents. The news and information presented on Patent Docs is provided by a group of patent practitioners holding doctorates in a diverse array of biotech and chemical disciplines.

Patent Law Weblog
recent posts
- Why the Alice Test is Stupid, Part IV: The Usefulness Paradox
- Teva Capitulates to Federal Trade Commission Coercion
- USPTO Issues Memoranda on Subject Matter Eligibility
- USPTO Revokes Guidance on AI-Assisted Inventorship, But Rules Remain Basically the Same
- Why the Alice Test is Stupid, Part III: Eligible Independent Claims Can Have Ineligible Dependent Claims
about
Posted in Miscellaneous
Leave a comment